Therakos cellex photopheresis system procedural kits

Ended Purchase Order Awarded Last action

Contract number
75N90024P00555
Awardee
Awarding agency
Obligated
$44,385

Award facts

Contract value 100% obligated
$44,385.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Hazelwood, MO 63042, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institutes of Health (NIH) Clinical Center awarded a $44,385 firm fixed-price purchase order to Therakos, Inc. to provide Therakos CELLEX Photopheresis System procedural kits. This award supports the NIH Clinical Center's medical research and patient care activities. Therakos, Inc. is a foreign-owned, for-profit corporation that specializes in photopheresis products and services. The company has held multiple Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA), including a $3.49 million Blanket Purchase Agreement and a $750,000 Federal Supply Schedule contract for hematology-related products. This purchase order does not have a set-aside designation.

Quick answers

Who was awarded contract 75N90024P00555?

75N90024P00555 was awarded to Therakos LLC by NIH Clinical Center (National Institutes of Health) on August 1, 2024.

How much is contract 75N90024P00555 worth?

The government has obligated $44,385 on 75N90024P00555.

Was contract 75N90024P00555 competed?

The extent of competition for 75N90024P00555 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award